Cambridge-based Moderna announces start of coronavirus vaccine testing

CAMBRIDGE, Mass. —The first test dose of a local company's vaccine intended to fight coronavirus infections was administered Monday.

Forty-five healthy adults will eventually be enrolled in the test, which is being conducted by the National Institutes of Health, Cambridge-based Moderna announced Monday.

Participants will receive two doses of the trial vaccine, administered 28 days apart. They will receive one of three different dosage amounts, as part of the test of safety and efficacy of the vaccine.

With a careful jab in a healthy volunteer’s arm Monday, scientists at the Kaiser Permanente Washington Research Institute in Seattle began the study.

More